Open AccessRelating In Vitro Neutralization Level and Protection in the CVnCoV (CUREVAC) Trial
Author(s) -
Deborah Cromer,
Arnold Reynaldi,
Megan Steain,
James A. Triccas,
Miles P. Davenport,
David S. Khoury
Publication year - 2022
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciac075
Subject(s) - medicine , neutralization , neutralizing antibody , covid-19 , in vitro , messenger rna , antibody , antibody response , virology , coronavirus , immunology , clinical trial , gene , outbreak , biology , biochemistry , disease , infectious disease (medical specialty)
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom